维普中文期刊产品整合服务
73篇 您的检索式:作者名="Neumiller"
    题名 作者 年代 出处 被引量
1Clinical Pharmacology of Incretin Therapies for Type 2 Diabetes Mellitus: Implications for Treatment显示文摘Joshua J. Neumiller 2011Clinical Therapeutics2011,,5:2
2Technosphere insulin:an inhaled prandial insulin product显示文摘NEUMILLER JJ CAMPBELL RK 2010Bio Drugs2010,24,3:1
3Clinical review of treatment options for select nonmotor symptoms of Parkinson's disease显示文摘Wood LD Neumiller JJ Setter SM 2010Am J Geriatr Pharmacother2010,8,4:1
4Empagliflozin: a new sodium-glucose co-transporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes 显示文摘Neumiller J J 2014Drugs Context2014,3,:1
5Pharmacology,efficacy,and safety of linagliptin for the treatment of type 2 diabetes mellitus显示文摘Neumiller JJ 2012Ann Pharmacother2012,46,3:1
6Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mel itus显示文摘Neumil er JJ Wood L Campbel RK 0,,:1
7Differential chemistry (structure),machanismof antion,and pharmacology of GLP-1 peceptoragonists and DPP-4 inhibitors显示文摘Neumiller JJ 2009J AM Pharm Assoc2009,,:1
8A review of inhaled technosphere insulin显示文摘NEUMILLER JJ CAMPBELL RK WOOD LD 2010Ann Pharmacother2010,44,78:1
9Sodium glucose co-transport inhibitiors: progress and therapeutic potential in type 2 disabets mellitus 显示文摘NEUMILLER J J WHITE J R caMPBELL R K 2010Drugs2010,70,4:1
10Aryl hydrocarbon receptor activation impairs the priming but not the recall of influenza virus-specific CD8 + T cells in the lung显示文摘Lawrence B P Roberts A D Neumiller J J 2006J Immunol2006,177,9:1
11Differential chemistry (structure), mechanism of action, and phannacology of GIP-1 receptor agonists and DPP-4 inhibitors显示文摘Neumiller JJ 2009J Am Pharm Assoc2009,,:1
12Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus 显示文摘Neumiller J J Wood L Campbell RK 2010Pharma- cotherapy2010,30,5:1
13Dipeptidyl peptidase4 inhibitors for the treatment of type 2 diabetes mellitus显示文摘Neumiller JJ Wood L Campbell RK 0,,:1
14Liraglutide:a once-daily incretin mimetic for the treatment of type 2 diabetes mellitus 显示文摘Neumiller JJ Campbell RK 2009Ann Pharmacother2009,43,9:1
15Dipeptidyl peptidase -4 inhibitors for the treatment of type 2 diabetes mellitus 显示文摘Neumiller JJ Wood L Campbell R K 2010Phar- macotherapy2010,30,5:1
16Sodiumglucose co-transport inhibitors progress and therapeutic potential in type 2 diabetes mellitus显示文摘Neumiller JJ White JR Jr Campbell RK 2010Drugs2010,70,4:1
17Pharmaeolo- gy,efficacy and safety of liraglutide in the management of type 2 diabetes 显示文摘Neumiller JL Sonnett TE Wood LD 2010Diabet Metab Synd Obes Targets Thero2010,3,:1
18Sodium-glucose co-transport inhibitors 显示文摘Neumiller JJ White JR Campbell RK 2010Drugs2010,70,4:1
19Sodiumglucose co-transport inhibitors: process and therapeutic potential in type 2 diabetes mellitus 显示文摘NEUMILLER JJ WHITE JR Jr CAMPBELL RK 2010Drugs2010,70,4:1
20Liraglutide: a once-daily incretin mimetic for the treatment of type 2 diabetes mellitus 显示文摘NEUMILLER J J CAMPBELL R K 2009Ann Pharmacother2009,43,9:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费